Pilot Study of Mature Dendritic Cell Vaccination Against Mutated KRAS in Patients With Resectable Pancreatic Cancer
The purpose of this pilot study is to evaluate the effects of a dendritic cell (a kind of white blood cell) vaccine for pancreatic cancer.
Study ID: UPCC 04218
Trial Phase: Pilot
Trial Sponsor: University of Pennsylvania Abramson Cancer Center
Therapies Used in This Trial: Dendritic Cell (DC) vaccine